Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer. | Cancer Immunol Immunother | 2023 | 36308553 | PubTator, text mining | PubMed |
| The correlation of CD70 in immune characteristics and drug therapy of pan-cancer. | Hum Cell | 2023 | 36260275 | PubTator, text mining | PubMed |
| Molecular landscape of immune pressure and escape in aplastic anemia. | Leukemia | 2023 | 36253429 | PubTator, text mining | PubMed |
| Genome-edited allogeneic donor "universal" chimeric antigen receptor T cells. | Blood | 2023 | 36223560 | PubTator, text mining | PubMed |
| When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders. | Clin Microbiol Infect | 2023 | 36209991 | PubTator, text mining | PubMed |
| Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis. | Int J Cancer | 2023 | 36151863 | PubTator, text mining | PubMed |
| Single-cell transcriptome landscape and antigen receptor dynamic during SARS-CoV-2 vaccination. | Genes Dis | 2023 | 36097543 | PubTator, text mining | PubMed |
| The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. | Hepatology | 2023 | 35989535 | PubTator, text mining | PubMed |
| FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy. | J Cancer Res Clin Oncol | 2023 | 35986757 | PubTator, text mining | PubMed |
| Epstein-Barr virus and multiple sclerosis. | Nat Rev Microbiol | 2023 | 35931816 | PubTator, text mining | PubMed |
Special issue "The advance of solid tumor research in China": Multi-omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response. | Int J Cancer | 2023 | 35579992 | PubTator, text mining | PubMed |
| Immune checkpoints in T cells during oncogenic γ-herpesvirus infections. | J Med Virol | 2023 | 35524342 | PubTator, text mining | PubMed |
| Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma. | J Oncol | 2022 | 37342680 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma. | Front Oncol | 2022 | 36733364 | PubTator, text mining | PubMed |
| Targeted thorium-227 conjugates as treatment options in oncology. | Front Med (Lausanne) | 2022 | 36726355 | PubTator, text mining | PubMed |
| [Relapse mechanism and coping strategies of CD19 chimeric antigen receptor T cells in the treatment of diffuse large B-cell lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709176 | PubTator, text mining | PubMed |
| [Update on biology of primary plasma cell leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709141 | PubTator, text mining | PubMed |
| [Progress in chimeric antigen receptor NK cell therapy for hematological malignancies]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709115 | PubTator, text mining | PubMed |
| Advances in immunotherapy modalities for atherosclerosis. | Front Pharmacol | 2022 | 36703734 | PubTator, text mining | PubMed |
| The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma. | Front Immunol | 2022 | 36700229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=49